康乃德生物医药(CNTB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CNTB 康乃德生物医药

未开盘 11-09 16:00:00 EST

0.7503

+0.0216

+2.96%

盘后0.7500

-0.0003-0.04%

19:27 EST

最高0.8000	最低0.7301	成交量27.15万
今开0.7400	昨收0.7287	日振幅9.59%
总市值4,724万	流通市值1,662万	总股本6,296万
成交额20.45万	换手率1.23%	流通股本2,215万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CNTB","market":"US","secType":"STK","nameCN":"康乃德生物医药","latestPrice":0.7503,"timestamp":1794258000000,"preClose":0.7287,"halted":0,"volume":271535,"hourTrading":{"tag":"盘后","latestPrice":0.75,"preClose":0.7503,"latestTime":"19:27 EST","volume":2607,"amount":1953.149554,"timestamp":1794270463112,"change":-0.0003,"changeRate":-0.0004,"amplitude":0.01306},"delay":0,"changeRate":0.029641827912721217,"floatShares":22145000,"shares":62963853,"eps":-1.193347,"marketStatus":"未开盘","change":0.0216,"latestTime":"11-09 16:00:00 EST","open":0.74,"high":0.8,"low":0.7301,"amount":204501.9854471,"amplitude":0.095924,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.193347,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794301200000},"marketStatusCode":0,"adr":0,"adrRate":1,"listingDate":1616126400000,"exchange":"NASDAQ","adjPreClose":0.7287,"preHourTrading":{"tag":"盘前","latestPrice":0.74,"preClose":0.7287,"latestTime":"09:27 EST","volume":2845,"amount":2101.705058,"timestamp":1794234427911,"change":0.0113,"changeRate":0.015507,"amplitude":0.013586},"postHourTrading":{"tag":"盘后","latestPrice":0.75,"preClose":0.7503,"latestTime":"19:27 EST","volume":2607,"amount":1953.149554,"timestamp":1794270463112,"change":-0.0003,"changeRate":-0.0004,"amplitude":0.01306},"volumeRatio":0.790427,"impliedVol":3.3337,"impliedVolPercentile":0.9283},"requestUrl":"/m/hq/s/CNTB","defaultTab":"news","newsList":[{"id":"2673006197","title":"康乃德：BML Investment Partners等持股426.44万股，占比6.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673006197","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673006197?lang=zh_cn&edition=full","pubTime":"2026-10-07 08:29","pubTimestamp":1791332940,"startTime":"0","endTime":"0","summary":"南财智讯10月7日电，康乃德（ConnectBiopharmaHoldingsLtd，纳斯达克：CNTB）向SEC提交了Schedule13G被动大股东持股声明文件。文件显示，截至当地时间2026年9月30日，申报人BMLInvestmentPartners,L.P.及BradenMLeonard合计受益持有公司426.44万股普通股，占公司已发行普通股约6.77%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610073888846025.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610073888846025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671202946","title":"康乃德：rademikibart二期COPD研究达主要终点，治疗失败率降低81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671202946","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671202946?lang=zh_cn&edition=full","pubTime":"2026-09-30 20:39","pubTimestamp":1790771940,"startTime":"0","endTime":"0","summary":"南财智讯9月30日电，康乃德（ConnectBiopharmaHoldingsLimited，纳斯达克：CNTB）提交8-K报告，披露9月30日公布全球二期SeabreezeSTATCOPD研究（CBP-201-207）的积极顶线数据。该研究评估rademikibart（新一代抗IL-4Rα抗体）作为标准治疗辅助方案，用于伴2型炎症的慢性阻塞性肺病（COPD）急性加重成人患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609303887878933.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609303887878933.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153083148","title":"康乃德生物医药：Rademikibart在哮喘患者中展现良好耐受性与低不良事件发生率","url":"https://stock-news.laohu8.com/highlight/detail?id=1153083148","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153083148?lang=zh_cn&edition=full","pubTime":"2026-09-15 19:08","pubTimestamp":1789470534,"startTime":"0","endTime":"0","summary":"在哮喘治疗领域，康乃德生物医药传来令人振奋的消息——其研发的药物Rademikibart展现出卓越的安全性特征。这一候选药物在患者群体中表现出良好的耐受性，同时不良反应的发生率维持在较低水平，为饱受哮喘困扰的患者带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183435314","title":"康乃德生物医药：Rademikibart在第7天展现统计学显著肺功能改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1183435314","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183435314?lang=zh_cn&edition=full","pubTime":"2026-09-15 19:08","pubTimestamp":1789470533,"startTime":"0","endTime":"0","summary":"康乃德生物医药（Connect Biopharma）近日披露，其候选药物Rademikibart在临床试验中展现出令人瞩目的积极信号。数据显示，与安慰剂对照组相比，接受该药物治疗的患者在用药后仅第7天便实现了肺功能的显著提升——这一差异在统计学上具有明确意义。此结果为该药物在呼吸系统疾病治疗领域的潜力增添了有力佐证，同时也为后续研发进程注入了强劲动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195209241","title":"康乃德生物医药公布Rademikibart全球II期研究积极初步顶线数据：作为成人与青少年哮喘合并2型炎症患者急性加重期的附加治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1195209241","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195209241?lang=zh_cn&edition=full","pubTime":"2026-09-15 19:01","pubTimestamp":1789470075,"startTime":"0","endTime":"0","summary":"康乃德生物医药今日宣布，其评估Rademikibart作为附加治疗药物、用于成人和青少年哮喘合并2型炎症患者急性加重期的全球II期研究，已取得令人振奋的初步顶线数据。这项备受瞩目的临床试验，旨在探究Rademikibart在缓解急性哮喘发作方面的潜力与安全性。Rademikibart若能成功研发上市，有望填补当前治疗策略中的重要空白，为患者提供更为精准和有效的干预手段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192576644","title":"奥本海默首予康乃德生物医药“跑赢大盘”评级，目标价8美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1192576644","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192576644?lang=zh_cn&edition=full","pubTime":"2026-07-09 20:27","pubTimestamp":1783600039,"startTime":"0","endTime":"0","summary":"投资机构奥本海默近日发布研报，首次将康乃德生物医药纳入研究覆盖范围，并给予其“跑赢大盘”的积极评级。该机构为这家生物技术公司设定的目标股价为每股8美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126934188","title":"Piper Sandler首予康乃德生物医药“增持”评级，目标价7美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126934188","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126934188?lang=zh_cn&edition=full","pubTime":"2026-06-26 15:40","pubTimestamp":1782459617,"startTime":"0","endTime":"0","summary":"投资银行Piper Sandler近日发布研究报告，首次覆盖康乃德生物医药，并给予其股票“增持”评级，同时设定7美元的目标价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131513063","title":"康乃德生物医药宣布完成评估雷迪米基巴治疗哮喘急性发作的II期海风研究患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1131513063","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131513063?lang=zh_cn&edition=full","pubTime":"2026-06-17 21:01","pubTimestamp":1781701278,"startTime":"0","endTime":"0","summary":"康乃德生物医药（Connect Biopharma Holdings Ltd.）已宣布其II期“海风”（Seabreeze）研究完成患者入组。该研究旨在评估其候选药物雷迪米基巴（rademikibart）用于治疗哮喘急性发作的疗效与安全性。这项关键性试验的推进，标志着公司在探索呼吸系统疾病创新疗法方面迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198980770","title":"康乃德生物医药控股有限公司 - 计划转售至多610万股普通股 - 美国证券交易委员会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1198980770","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198980770?lang=zh_cn&edition=full","pubTime":"2026-05-15 20:34","pubTimestamp":1778848459,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）提交的文件，康乃德生物医药控股有限公司（Connect Biopharma Holdings Ltd.）计划进行一项普通股转售。文件显示，此次拟议的转售涉及高达610万股公司普通股。\n这一行动通常意味着现有股东，例如早期投资者或公司内部人士，可能计划在公开市场上出售其持有的部分股份。此类转售备案是资本市场中的常规操作，旨在提前向市场披露潜在的股票供应增加，确保信息的透明性。投资者通常会关注此类动向，以评估其对公司股价可能产生的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114135897","title":"康乃德生物医药：两项Seabreeze Stat研究顶线结果预计年中公布，目前进展顺利","url":"https://stock-news.laohu8.com/highlight/detail?id=1114135897","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114135897?lang=zh_cn&edition=full","pubTime":"2026-05-12 21:13","pubTimestamp":1778591604,"startTime":"0","endTime":"0","summary":"康乃德生物医药目前进展顺利，预计仍将按计划于今年年中公布其两项Seabreeze Stat研究的关键顶线结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518279704","title":"康乃德生物盘中异动 早盘快速跳水5.88%报0.800美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518279704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518279704?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:15","pubTimestamp":1741619739,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时15分，康乃德生物股票出现异动，股价快速下挫5.88%。截至发稿，该股报0.800美元/股，成交量3951股，换手率0.01%，振幅3.53%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康乃德生物股票所在的生物技术行业中，整体涨幅为0.76%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023153998a2b5b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023153998a2b5b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517848161","title":"康乃德生物盘中异动 股价大跌5.68%报0.830美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517848161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517848161?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:12","pubTimestamp":1741273951,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时12分，康乃德生物股票出现异动，股价快速下挫5.68%。截至发稿，该股报0.830美元/股，成交量1691股，换手率0.00%，振幅0.00%。康乃德生物股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Plus Therapeutics, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Aditxt, Inc.较为活跃，换手率分别为1506.68%、827.09%、75.14%，振幅较大的相关个股有Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Moolec Science Sa C/Wts ，振幅分别为48.42%、44.64%、44.44%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306231231abeb827f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306231231abeb827f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517894669","title":"康乃德生物盘中异动 早盘股价大涨10.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517894669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517894669?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:36","pubTimestamp":1741188983,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时36分，康乃德生物股票出现异动，股价快速上涨10.27%。截至发稿，该股报0.905美元/股，成交量2326股，换手率0.00%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康乃德生物股票所在的生物技术行业中，整体涨幅为1.23%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233623abe9c593&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233623abe9c593&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516608274","title":"康乃德生物盘中异动 早盘股价大跌8.33%报0.800美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516608274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516608274?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:07","pubTimestamp":1741100876,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时07分，康乃德生物股票出现异动，股价急速跳水8.33%。截至发稿，该股报0.800美元/股，成交量297股，换手率0.00%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康乃德生物股票所在的生物技术行业中，整体涨幅为0.40%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030423075696394f6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030423075696394f6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516637820","title":"康乃德生物盘中异动 快速跳水6.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637820","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516637820?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:39","pubTimestamp":1741012756,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时39分，康乃德生物股票出现异动，股价大幅跳水6.99%。截至发稿，该股报0.846美元/股，成交量516股，换手率0.00%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康乃德生物股票所在的生物技术行业中，整体涨幅为0.11%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223916989a1197&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223916989a1197&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514758793","title":"康乃德生物盘中异动 早盘股价大跌6.45%报0.841美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514758793","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514758793?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:14","pubTimestamp":1740755686,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时14分，康乃德生物股票出现异动，股价快速下跌6.45%。截至发稿，该股报0.841美元/股，成交量1275股，换手率0.00%，振幅0.00%。康乃德生物股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Bioxcel Therapeutics, Inc.、Immunitybio, Inc.、Enveric Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1217.59%、397.70%、328.84%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Bioxcel Therapeutics, Inc.，振幅分别为46.60%、43.37%、38.73%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231447989683d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231447989683d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514385837","title":"康乃德生物盘中异动 大幅拉升9.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514385837?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:31","pubTimestamp":1740666690,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时31分，康乃德生物股票出现异动，股价大幅上涨9.86%。截至发稿，该股报0.928美元/股，成交量511股，换手率0.00%，振幅0.00%。康乃德生物股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Quoin Pharmaceuticals Ltd、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为401.98%、90.33%、49.86%，振幅较大的相关个股有天演药业、Syros Pharmaceuticals, Inc.、内克塔治疗，振幅分别为10.10%、10.09%、7.64%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223130a25679c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223130a25679c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513349296","title":"康乃德生物盘中异动 早盘大幅上涨5.74%报0.909美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513349296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513349296?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:35","pubTimestamp":1740148532,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时35分，康乃德生物股票出现波动，股价急速拉升5.74%。截至发稿，该股报0.909美元/股，成交量329股，换手率0.00%，振幅0.00%。康乃德生物股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为72.60%、65.04%、16.47%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Osr Holdings Inc C/Wts 09/02/2028 、Osr Holdings, Inc.，振幅分别为33.83%、30.00%、25.39%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223533a24eb16d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223533a24eb16d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511548572","title":"康乃德生物盘中异动 下午盘急速上涨5.69%报0.970美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511548572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511548572?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:29","pubTimestamp":1739478564,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日04时29分，康乃德生物股票出现异动，股价大幅拉升5.69%。截至发稿，该股报0.970美元/股，成交量1376股，换手率0.00%，振幅5.69%。康乃德生物股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Dominari Holdings Inc.涨幅较大，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3257.93%、2259.49%、1260.92%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为733.31%、95.15%、92.30%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140429249884718d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140429249884718d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510334863","title":"康乃德生物盘中异动 临近午盘急速拉升12.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510334863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510334863?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:41","pubTimestamp":1739292061,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日00时41分，康乃德生物股票出现异动，股价急速拉升12.95%。截至发稿，该股报1.040美元/股，成交量355股，换手率0.00%，振幅0.00%。康乃德生物股票所在的生物技术行业中，整体跌幅为1.37%。其相关个股中，Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2970.64%、1296.34%、432.37%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为103.43%、59.46%、58.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212004101abcb2224&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212004101abcb2224&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.connectbiopharm.com","stockEarnings":[{"period":"1week","weight":-0.0345},{"period":"1month","weight":-0.1376},{"period":"3month","weight":-0.665},{"period":"6month","weight":-0.6938},{"period":"1year","weight":-0.5159},{"period":"ytd","weight":-0.7339}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.0332},{"period":"3month","weight":-0.0232},{"period":"6month","weight":0.014},{"period":"1year","weight":0.1218},{"period":"ytd","weight":0.1038}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"康乃德生物制药控股有限公司于2015年11月23日在开曼群岛注册成立。该公司是一家临床阶段的生物制药公司，致力于改变哮喘和慢性阻塞性肺疾病（“COPD”）的护理方式。该公司正在推进rademikibart，这是一种下一代可能是同类中最好的抗体，旨在靶向白细胞介素-4受体α（“IL-4Rα”）。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.028496},{"month":2,"riseRate":0.6,"avgChangeRate":-0.025044},{"month":3,"riseRate":0.4,"avgChangeRate":-0.062942},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.024639},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.059238},{"month":6,"riseRate":0.666667,"avgChangeRate":0.069047},{"month":7,"riseRate":0.333333,"avgChangeRate":0.10035},{"month":8,"riseRate":0.833333,"avgChangeRate":0.185246},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.153579},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.03869},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.10116},{"month":12,"riseRate":1,"avgChangeRate":0.142382}],"exchange":"NASDAQ","name":"康乃德生物医药","nameEN":"Connect Biopharma Holdings Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康乃德生物医药(CNTB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康乃德生物医药(CNTB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康乃德生物医药,CNTB,康乃德生物医药股票,康乃德生物医药股票老虎,康乃德生物医药股票老虎国际,康乃德生物医药行情,康乃德生物医药股票行情,康乃德生物医药股价,康乃德生物医药股市,康乃德生物医药股票价格,康乃德生物医药股票交易,康乃德生物医药股票购买,康乃德生物医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康乃德生物医药(CNTB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康乃德生物医药(CNTB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}